z-logo
open-access-imgOpen Access
The Role of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone Diseases1
Author(s) -
Lorenz C. Hofbauer,
Armin E. Heufelder
Publication year - 2000
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jcem.85.7.6702
Subject(s) - osteoprotegerin , endocrinology , medicine , activator (genetics) , pathogenesis , receptor , rankl , rank ligand , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom